Categories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide sodium salt
(75081519 | 129541-41-9)
| CAS: | 129541-41-9 |
|---|---|
| Molecular Formula: | C14H12BrClNNaO7 |
| Molecular Weight: | 444.59 |
| Availablility: | In Stock |
|---|---|
| Downloads: | | |
| 75081519-100mg | 100mg | £143.90 | |
| 75081519-1g | 1g | £197.70 | |
| Bulk Order | |||
| 75081519-100mg | 100mg | €201.50 | |
| 75081519-1g | 1g | €276.80 | |
| Bulk Order | |||
| 75081519-100mg | 100mg | $215.90 | |
| 75081519-1g | 1g | $296.60 | |
| Bulk Order | |||
Safety Data Sheet
Specification
Product Detail
| Product Code | 75081519 | ||||
| Product Name | 5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide sodium salt | ||||
| Categories | Analytical Reagents Biochemicals Building Blocks Diagnostic Raw Materials Stains & Indicators | ||||
| CAS | 129541-41-9 | ||||
| Molecular Formula | C14H12BrClNNaO7 | ||||
| Molecular Weight | 444.59 | ||||
| Storage Details | -15 to -20 °C | ||||
| Harmonised Tariff Code | 2934999090 |
Product Specification
| Appearance | white/ off white solid |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|